51 found
Order:
Disambiguations
Jeffrey P. Kahn [33]Jeffrey Kahn [18]Jeffrey Paul Kahn [1]
  1.  33
    Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations.Susan M. Wolf, Frances P. Lawrenz, Charles A. Nelson, Jeffrey P. Kahn, Mildred K. Cho, Ellen Wright Clayton, Joel G. Fletcher, Michael K. Georgieff, Dale Hammerschmidt, Kathy Hudson, Judy Illes, Vivek Kapur, Moira A. Keane, Barbara A. Koenig, Bonnie S. LeRoy, Elizabeth G. McFarland, Jordan Paradise, Lisa S. Parker, Sharon F. Terry, Brian Van Ness & Benjamin S. Wilfond - 2008 - Journal of Law, Medicine and Ethics 36 (2):219-248.
    No consensus yet exists on how to handle incidental fnd-ings in human subjects research. Yet empirical studies document IFs in a wide range of research studies, where IFs are fndings beyond the aims of the study that are of potential health or reproductive importance to the individual research participant. This paper reports recommendations of a two-year project group funded by NIH to study how to manage IFs in genetic and genomic research, as well as imaging research. We conclude that researchers (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   83 citations  
  2.  56
    Public Health Ethics: Mapping the Terrain.James F. Childress, Ruth R. Faden, Ruth D. Gaare, Lawrence O. Gostin, Jeffrey Kahn, Richard J. Bonnie, Nancy E. Kass, Anna C. Mastroianni, Jonathan D. Moreno & Phillip Nieburg - 2002 - Journal of Law, Medicine and Ethics 30 (2):170-178.
  3.  10
    A Conceptual Model for the Translation of Bioethics Research and Scholarship.Debra J. H. Mathews, D. Micah Hester, Jeffrey Kahn, Amy McGuire, Ross McKinney, Keith Meador, Sean Philpott-Jones, Stuart Youngner & Benjamin S. Wilfond - 2016 - Hastings Center Report 46 (5):34-39.
    While the bioethics literature demonstrates that the field has spent substantial time and thought over the last four decades on the goals, methods, and desired outcomes for service and training in bioethics, there has been less progress defining the nature and goals of bioethics research and scholarship. This gap makes it difficult both to describe the breadth and depth of these areas of bioethics and, importantly, to gauge their success. However, the gap also presents us with an opportunity to define (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  4.  60
    Sunset on the RAC: When Is It Time to End Special Oversight of an Emerging Biotechnology?Jeffrey P. Kahn & Anna C. Mastroianni - 2018 - American Journal of Bioethics 18 (12):1-2.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  54
    Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field.Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline - 2012 - Journal of Law, Medicine and Ethics 40 (4):716-750.
    The nanomedicine field is fast evolving toward complex, “active,” and interactive formulations. Like many emerging technologies, nanomedicine raises questions of how human subjects research (HSR) should be conducted and the adequacy of current oversight, as well as how to integrate concerns over occupational, bystander, and environmental exposures. The history of oversight for HSR investigating emerging technologies is a patchwork quilt without systematic justification of when ordinary oversight for HSR is enough versus when added oversight is warranted. Nanomedicine HSR provides an (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  6. Beyond Consent: Seeking Justice in Research.Jeffrey P. Kahn, Anna C. Mastroianni & Jeremy Sugarman (eds.) - 1998 - Oup Usa.
    Beyond Consent examines the concept of justice, and its application to human subject research, through the different lenses of various research populations: children, the vulnerable sick, captive and convenient populations, women, people of colour, and subjects in international settings. Separate chapters address the evolution of research policies, implications of the concept of justice for the future of human subject research, and the ramifications of this concept throughout the research enterprise.
    No categories
     
    Export citation  
     
    Bookmark   12 citations  
  7.  44
    Pharmacogenetics: Ethical Issues and Policy Options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
    : Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. Before the benefits of pharmacogenetics can be realized, the ethical issues that arise in research and clinical application of pharmacogenetic technologies must be addressed. The ethical issues raised by pharmacogenetics can be addressed under six headings: regulatory oversight, confidentiality and privacy, informed consent, availability of drugs, access, and clinicians' changing responsibilities in the era of pharmacogenetic medicine. We (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  8.  19
    The Task Force Responds.Baruch Brody, Nancy Dubler, Jeff Blustein, Arthur Caplan, Jeffrey P. Kahn, Nancy Kass, Bernard Lo, Jonathan Moreno, Jeremy Sugarman & Laurie Zoloth - 2002 - Hastings Center Report 32 (3):22-23.
  9.  17
    CONCEPTION to Obtain Hematopoietic Stem Cells.John A. Robertson, Jeffrey P. Kahn & John E. Wagner - 2002 - Hastings Center Report 32 (3):34-40.
  10.  23
    Lessons Learned: Challenges in Applying Current Constraints on Research on Chimpanzees to Other Animals.Jeffrey Kahn - 2014 - Theoretical Medicine and Bioethics 35 (2):97-104.
    The Institute of Medicine (IOM) Committee on the Necessity of the Use of Chimpanzees in Biomedical and Behavioral Research made a series of recommendations that, as of an announcement on June 26, 2013, the National Institutes of Health (NIH) is turning into implemented guidelines. Many advocates, including some researchers and scholars, have suggested that the Committee’s recommendations could be applied successfully to other animal species. This article examines, from my perspective as the IOM Committee’s chair, some of the most important (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  11.  7
    Swinging on the Pendulum: Shifting Views of Justice in Human Subjects Research.Anna Mastroianni & Jeffrey Kahn - 2001 - Hastings Center Report 31 (3):22-24.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  12.  27
    Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-339.
  13.  1
    Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-339.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  14.  44
    Three Views of Organ Procurement Policy: Moving Ahead or Giving Up?Jeffrey P. Kahn - 2003 - Kennedy Institute of Ethics Journal 13 (1):45-50.
    : The supply of organs for transplant remains inadequate to meet the needs of waiting patients, in spite of many programs and approaches to increase rates of donation. Over the years there have been numerous proposals to introduce schemes that would move toward the outright sale of organs. Three articles in this issue of the Journal propose methods for increasing organ supply—two by moving toward a market approach and the third by advocating a change in social culture. All three suffer (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  15.  31
    American College of Epidemiology Ethics Guidelines: Foundations and Dissemination.Robert E. McKeown, Douglas L. Weed, Jeffrey P. Kahn & Michael A. Stoto - 2003 - Science and Engineering Ethics 9 (2):207-214.
    Epidemiology is a core science of public health, focusing on research related to the distribution and determinants of both positive and adverse health states and events and on application of knowledge gained to improve public health. The American College of Epidemiology (ACE) is a professional organization devoted to the professional practice of epidemiology. As part of that commitment, and in response to concerns for more explicit attention to core values and duties of epidemiologists in light of emerging issues and increased (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  16.  33
    Bioethics Matures: The Field Faces the Future.Susan M. Wolf & Jeffrey P. Kahn - 2005 - Hastings Center Report 35 (4):22-24.
  17.  8
    Genetic Harm: Bitten by the Body That Keeps You?Jeffrey P. Kahn - 1991 - Bioethics 5 (4):289–308.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  18.  10
    Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy.Susan M. Wolf & Jeffrey P. Kahn - 2007 - Journal of Law, Medicine and Ethics 35 (s2):6-32.
    Predictive genetic testing poses fundamental questions for disability insurance, a crucial resource funding basic needs when disability prevents income from work. This article, from an NIH-funded project, presents the first indepth analysis of the challenging issues: Should disability insurers be permitted to consider genetics and exclude predicted disability? May disabilities with a recognized genetic basis be excluded from coverage as pre-existing conditions? How can we assure that private insurers writing individual and group policies, employers, and public insurers deal competently and (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  19.  8
    What Happens When Politics Discovers Bioethics?Jeffrey P. Kahn - 2006 - Hastings Center Report 36 (3):10-10.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  20.  1
    Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy.Susan M. Wolf & Jeffrey P. Kahn - 2007 - Journal of Law, Medicine and Ethics 35 (2_suppl):6-32.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  21.  4
    Making the Most of Strangers' Altruism.Jeffrey Kahn - 2002 - Journal of Law, Medicine and Ethics 30 (3):446-447.
  22.  48
    Creating a Stem Cell Donor: A Case Study in Reproductive Genetics.Jeffrey P. Kahn & Anna C. Mastroianni - 2004 - Kennedy Institute of Ethics Journal 14 (1):81-96.
    : During the nearly 10 years since its introduction, preimplantation genetic diagnosis (PGD) has been used predominantly to avoid giving birth to a child with identified genetic disease. Recently, PGD was used by a couple not only to test IVF-created embryos for genetic disease, but also to test for a nondisease trait related to immune compatibility with a child in the family in need of an hematopoetic stem cell transplant. This article describes the case, raises some ethical and policy issues, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  23. Cross-Cultural Biotechnology: A Reader.Stella Gonzalez Arnal, Donald Chalmers, David Kum-Wah Chan, Margaret Coffey, Jo Ann T. Croom, Mylène Deschênes, Henrich Ganthaler, Yuri Gariev, Ryuichi Ida, Jeffrey P. Kahn, Martin O. Makinde, Anna C. Mastroianni, Katharine R. Meacham, Bushra Mirza, Michael J. Morgan, Dianne Nicol, Edward Reichman, Susan E. Wallace & Larissa P. Zhiganova - 2004 - Rowman & Littlefield Publishers.
    This book is a rich blend of analyses by leading experts from various cultures and disciplines. A compact introduction to a complex field, it illustrates biotechnology's profound impact upon the environment and society. Moreover, it underscores the vital relevance of cultural values. This book empowers readers to more critically assess biotechnology's value and effectiveness within both specific cultural and global contexts.
     
    Export citation  
     
    Bookmark   1 citation  
  24.  15
    Can We Broker Eggs Without Making Omelets?Jeffrey Kahn - 2001 - American Journal of Bioethics 1 (4):14 – 15.
  25.  4
    Looking Forward in Bioethics.Jeffrey Kahn & Anna Mastroianni - 2004 - Journal of Law, Medicine and Ethics 32 (2):196-197.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  26. Conception.John A. Robertson, Jeffrey P. Kahn & John E. Wagner - forthcoming - Hastings Center Report.
     
    Export citation  
     
    Bookmark  
  27.  4
    It's a Small World After All: Ethics and the Response to SARS.Jeffrey Kahn - 2003 - Hastings Center Report 33 (3):6-6.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  28.  10
    Docs on the Box Or, How We Learned to Stop Worrying and Love the Tube.Carl Elliott & Jeffrey Kahn - 1994 - Hastings Center Report 24 (6):22-23.
  29.  2
    Genetic Harm: Bitten by the Body That Keeps You?Jeffrey P. Kahn - 1991 - Bioethics 5 (4):289-308.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  30.  15
    Remedies for Human Subjects of Cold War Research: Recommendations of the Advisory Committee.Anna Mastroianni & Jeffrey Kahn - 1996 - Journal of Law, Medicine and Ethics 24 (2):118-126.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  31.  14
    By Author BAGHERI, Alireza. Criticism of “Brain.Tom L. Beauchamp, Howard Brody, Franklin G. Miller, Alexander S. Curtis, Martina Darragh, Patricia Milmoe, Ronald M. U. S. Green, Sharona Hoffman, Edmund G. Howe & Jeffrey P. Kahn - 2003 - Kennedy Institute of Ethics Journal 13 (4):407-09.
  32.  24
    Organs and Stem Cells: Policy Lessons and Cautionary Tales.Jeffrey P. Kahn - 2007 - Hastings Center Report 37 (2):11-12.
  33.  9
    Looking Forward in Bioethics.Jeffrey Kahn & Anna Mastroianni - 2004 - Journal of Law, Medicine and Ethics 32 (2):196-197.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  34.  7
    The Implications of Public Health for Bioethics.Jeffrey Kahn & Anna Mastroianni - 2009 - In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press.
    At its core, public health introduces tensions between individuals' autonomy and the need to account for the perspectives and needs of communities and populations. It further raises social justice issues, including fair allocation of limited resources. This article examines and elaborates on these tensions and their resolutions using specific public health examples. Experiences in the 1980s and 1990s with HIV/AIDS provide a particularly rich collection of issues that brought ethical issues in public health to the public's attention, and in so (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  35.  8
    Remedies for Human Subjects of Cold War Research: Recommendations of the Advisory Committee.Anna Mastroianni & Jeffrey Kahn - 1996 - Journal of Law, Medicine and Ethics 24 (2):118-126.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  36.  8
    Genetic Counselors' Impact on the Genetics Revolution: Recommendations of an Informed Outsider.Jeffrey Kahn - 2004 - Bioethics Examiner 8.
  37.  5
    Raising the Bar: The Implications of the IOM Report on the Use of Chimpanzees in Research.Jeffrey Kahn - 2012 - Hastings Center Report 42 (s1):S27 - S30.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  38.  9
    Baseball, Alcohol and Public Health.Jeffrey P. Kahn - 2007 - American Journal of Bioethics 7 (7):3.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  39.  10
    Commentary on Zohar's "Prospects For'genetic Therapy'- Can a Person Benefit From Being Altered?".Jeffrey P. Kahn - 1991 - Bioethics 5 (4):312–317.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  40.  6
    Introduction.P. Kahn Jeffrey & C. Mastroianni Anna - 1996 - Kennedy Institute of Ethics Journal 6 (3):ix-xi.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  41.  7
    What Vaccination Programs Mean for Research.Jeffrey Kahn - 2007 - American Journal of Bioethics 7 (3):3 – 4.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  42.  1
    Toward Justice in Human Subjects ResearchBeyond Consent: Seeking Justice in Research.Lisa Sowle Cahill, Jeffrey P. Kahn, Anna C. Mastroianni & Jeremy Sugarman - 2000 - Hastings Center Report 30 (4):45.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  43.  3
    Understanding the Role of Genetics in Disability Insurance.Jeffrey P. Kahn & Susan M. Wolf - 2007 - Journal of Law, Medicine and Ethics 35 (s2):5-5.
  44.  4
    Why Public Health and Politics Don't Mix.Jeffrey P. Kahn - 2007 - American Journal of Bioethics 7 (11):3 – 4.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  45.  2
    An Unprotected Public.Jeffrey Kahn - 2008 - American Journal of Bioethics 8 (6):3 – 4.
  46.  2
    Letter to the Editor.Jeffrey P. Kahn - 2005 - American Journal of Bioethics 5 (3):W13-W13.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  47.  1
    Commentary on Zohar's “Prospects for‘Genetic Therapy’‐ Can a Person Benefit From Being Altered?”.Jeffrey P. Kahn - 1991 - Bioethics 5 (4):312-317.
    Direct download  
     
    Export citation  
     
    Bookmark  
  48.  3
    Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
    This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  49.  1
    Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  50.  1
    Understanding the Role of Genetics in Disability Insurance.Jeffrey P. Kahn & Susan M. Wolf - 2007 - Journal of Law, Medicine and Ethics 35 (2_suppl):5-5.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
1 — 50 / 51